Tian'an Technology (TANAF) Change in Account Payables (2022 - 2025)
Tian'an Technology (TANAF) posted Change in Account Payables of $1138.0 for Q2 2025, down 90.63% on a QoQ basis from $12142.0 in Q2 2023.
Tian'an Technology (TANAF) has 3 years of Change in Account Payables data on file, last reported at $1138.0 in Q2 2025.
- In Q2 2025, Change in Account Payables changed N/A year-over-year to $1138.0; the TTM figure through Jun 2025 stood at $1138.0 (changed N/A YoY), while the FY2025 annual figure was $4893.0, changed N/A from the prior year.
- Change in Account Payables fell to $1138.0 in Q2 2025, from $12142.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $12142.0 in Q2 2023 and bottomed at $83.0 in Q4 2022.
- A 3-year average of $4454.3 and a median of $1138.0 in 2025 frame the typical range for Change in Account Payables.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -198.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 221.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 56.90 Mn |
| 10 | Tian'an Technology | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1,138.00 |
| Jun 30, 2025 | 1,138.00 |
| Jun 30, 2023 | 12,142.00 |
| Jun 30, 2023 | 12,142.00 |
| Dec 31, 2022 | 83.00 |
| Dec 31, 2022 | 83.00 |